MedPath

A Multi-Center Study to Assess the Performance of Saturation Patterns.

Completed
Conditions
Sleep Apnea
Obstructive Sleep Apnea
Sleep-Disordered Breathing
Central Sleep Apnea
Registration Number
NCT00775346
Lead Sponsor
Medtronic - MITG
Brief Summary

A multi-center, prospective, single-visit study designed to acquire physiologic pulse oximeter waveform data during standard polysomnography (PSG) studies performed at multiple different Sleep Lab Centers.

Detailed Description

The polysomnograms are clinically indicated studies in patients suspected of having sleep-disordered breathing, including, but not limited to: obstructive sleep apnea, complex sleep apnea and/or central sleep apnea. Subjects who have been prescribed with needing a polysomnography (PSG) will be enrolled into the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
92
Inclusion Criteria
  • Subjects will be referred to the Sleep Lab Center for evaluation of possible sleep-disordered breathing.
  • Polysomnography (PSG) is obtained as part of normal, standard clinical practice.
  • Subject is able to and willingly signs the informed consent form.
Exclusion Criteria
  • Subject and/or parent/legal guardian is, in the opinion of the investigator, mentally and/or physically unable to provide informed consent/child assent and/or to complete all requirements of the protocol.
  • Subject is currently participating in or has participated in an investigational drug study within seven (7) days of enrollment.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity and Specificity Data of the Saturation Pattern Detection (SPD) Feature as a Predictor of Repetitive Reductions in Airflow (RRiA).9 Hours

Sensitivity and specificity were computed from the count of instances in which the Saturation Pattern Detection (SPD) index value (vs. Polysomnography) within a discrete ten minute interval correctly identified a Repetitive Reduction in Airflow (RRiA) as being present within that interval (True Positive), absent (True Negative), or incorrectly identified presence or absence (False Positive and False Negative, respectively). Sensitivity is True Positive divided by True Positive plus False Negative TP/(TP+FN). Specificity is True Positive divided by True Negative plus False Positive TP/(TN+FP).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Clayton Sleep Institute

🇺🇸

Maplewood, Missouri, United States

SleepFit

🇺🇸

Broomfield, Colorado, United States

Sleep Medicine Centers

🇺🇸

West Seneca, New York, United States

© Copyright 2025. All Rights Reserved by MedPath